Cerity Partners LLC Alaunos Therapeutics, Inc. Transaction History

Cerity Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$0.04 - $0.13 $24 - $78	600 Added 1.11%	54,600 $3,000
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.5 $1,632 - $6,800	-13,600 Reduced 20.12%	54,000 $7,000
Q2 2023 Aug 14, 2023	BUY	$0.43 - $0.65 $11,438 - $17,290	26,600 Added 64.88%	67,600 $34,000
Q1 2023 May 11, 2023	BUY	$0.46 - $0.81 $18,860 - $33,210	41,000 New	41,000 $25,000
Q1 2022 Apr 25, 2022	BUY	$0.62 - $1.17 $8,432 - $15,911	13,600 New	13,600 $9,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.